SEARCH SITE

VIRGINIA LAW PORTAL

SEARCHABLE DATABASES

ACROSS SESSIONS

Developed and maintained by the Division of Legislative Automated Systems.

2019 SESSION

  • | print version

HB 2248 Pharmacy; practice, regulation by Board of Pharmacy.

Introduced by: John J. Bell | all patrons    ...    notes | add to my profiles

SUMMARY AS INTRODUCED:

Practice of pharmacy; regulation by Board of Pharmacy. Provides that compounding of drugs provided to the Department of Corrections for the purpose of carrying out an execution by lethal injection shall constitute the practice of pharmacy and be subject to the requirements of the Drug Control Act and the jurisdiction of the Board of Pharmacy. The bill provides that only outsourcing facilities may compound such drugs; currently, both pharmacies and outsourcing facilities may compound such drugs. The bill also clarifies that the Board of Pharmacy may inspect any pharmacy or other place where drugs, cosmetics, or devices are manufactured, stored, or dispensed in response to complaints received by the Board, in any case in which the Board has reason to believe that the pharmacy or other place where drugs, cosmetics, or devices are manufactured, stored, or dispensed has violated any state or federal law, or as otherwise deemed necessary by the Board to protect the health and safety of the public. The bill amends the membership of the Board of Health to include a pharmacist with experiencing in compounding, requires the Board of Health to educate the public about safe use of compounded drugs, and requires the Board of Health and the Board of Pharmacy to report annually to the Governor and the General Assembly on actions taken to (i) ensure the safety and quality of compounded drugs produced by compounding pharmacies and outsourcing facilities located in the Commonwealth and compounding pharmacies and outsourcing facilities located outside the Commonwealth that provide compounded drugs to patients in the Commonwealth; (ii) reduce illegal use of opioids and opioid abuse in the Commonwealth; and (iii) implement provisions of and ensure compliance with the requirements of Title II of the federal Drug Supply Chain Security Act of 2013 related to prescription drug identification, tracing, and verification.


FULL TEXT

HISTORY